Noven Pharmaceuticals Inc.

06/05/2023 | Press release | Distributed by Public on 06/05/2023 06:49

XELSTRYM™ (dextroamphetamine) Transdermal System, CII, the First and Only Amphetamine Patch, Now Available for the Treatment of Attention- Deficit/Hyperactivity Disorder (ADHD)[...]